AHP Redux Settlement Doubles Cash Payments For Use Of Drug Over 60 Days
Executive Summary
Patients who used American Home Products' Redux or Pondimin for more than 60 days would be eligible to receive a cash payment of $6,000 if an echocardiogram shows heart valve regurgitation, while those who used the drugs for 60 days or less could receive $3,000, under a settlement proposed by AHP.
You may also be interested in...
Redux Settlement Does Not Settle All Questions About AHP's Future
American Home Products is off to a strong start to the fourth quarter on Wall Street thanks to the Redux settlement, but the long term prospects for the company remain unsettled.
Redux Settlement Does Not Settle All Questions About AHP's Future
American Home Products is off to a strong start to the fourth quarter on Wall Street thanks to the Redux settlement, but the long term prospects for the company remain unsettled.
Interneuron Redux Settlement Offer Denied Due To Valuation "Uncertainty"
The unpredictability of Interneuron's future cash-flow served as a basis of Eastern District of Pennsylvania Judge Louis Bechtle's Sept. 27 decision to deny the company's proposed settlement for diet drug Redux medical claims.